Background: Cisplatin-based NAC is considered as standard of care for NM-MIBC pts based on a modest survival benefit correlated with pathological complete ...
As of the data cut-off date for this final analysis (May 31, 2024), median fol- low-up was 37 (0-56) months, and total person-years follow-up was 304.7. Median ...
The data cut-off date for this report was June 17, 2019. The boundaries, colors, denominations, and other information shown on any map in this work do not imply ...
This review explores novel therapeutic regimens under investigation for enhancing responses to PD-(L)1 inhibitors and countering resistance, and summarizes the ...
Chapter 5. Can major cardiac events during and after native coronary balloon angioplasty be predicted from quantitative and qualitative angiographic lesion ...